Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

This study is evaluating a urine-based test called BCDx to detect whether bladder cancer has come back in people with non-muscle invasive bladder cancer (NMIBC). The test is used alongside standard surveillance procedures such as cystoscopy (a camera examination of the bladder). **You may be eligible if:** - You are 18 or older - You have been diagnosed with non-muscle invasive bladder cancer (NMIBC) within the past 2 years - You are currently undergoing routine bladder cancer monitoring with cystoscopy - You are able to provide at least 30 mL of urine **You may NOT be eligible if:** - You are planning to have your bladder removed or receive chemotherapy-radiation treatment for bladder cancer Talk to your doctor to see if this trial is right for you.